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Abstract
Background: The great interest in cell-free mRNA, microRNA (miRNA) as molecular biomarkers for clinical applications, and
as ‘signaling’ molecules for intercellular communication highlights the need to reveal their physical nature. Here this issue
was explored in human cell-free seminal mRNA (cfs-mRNA) and miRNA (cfs-miRNA).
Methodology/Principal Findings: Selected male reproductive organ-specific mRNAs, miRNAs, and piRNAs were quantified
by quantitative real-time PCR in all experiments. While the stability of cfs-miRNA assessed by time-course analysis (up to
24 h at room temperature) was similar with cfs-mRNA, the reductive changes between cfs-miRNA and cfs-mRNA after
filtration and Triton X-100 treatment on seminal plasma were very different, implying their different physical nature. Seminal
microvesicles (SMVs) were then recovered and proportions of cfs-mRNA and cfs-miRNA within SMVs were quantified. The
amounts of SMVs- sequestered cfs-mRNAs almost were the same as total cfs-mRNA, and were highly variable depending on
the different sizes of SMVs. But most of cfs-miRNA was independent of SMVs and existed in the supernatant. The possible
form of cfs-miRNA in the supernatant was further explored by filtration and protease K digestion. It passed through the
0.10-mm pore, but was degraded dramatically after intense protease K digestion.
Conclusions/Significance: The predominant cfs-mRNA is contained in SMVs, while most cfs-miRNA is bound with protein
complexes. Our data explained the stability of extracellular RNAs in human semen, and shed light on their origins and
potential functions in male reproduction, and strategy of developing them as biomarkers of male reproductive system.
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Introduction
Cell-free RNAs, including mRNAs and miRNAs, are extracel-
lular RNAs existing outside cells. In recent years, much interest
has been focused on the potential diagnostic application and
function of cell-free RNAs in human body fluids. Cell-free RNAs
have been detected in many kinds of human body fluids and
reported as promising biomarkers for various pathologic condi-
tions, including cancer detection and prognosis [1,2], prenatal
diagnosis [3,4], pregnancy monitoring [5,6], tissue injury [7–9],
cardiovascular diseases [10], metabolic disorders [11], and forensic
identification [12,13]. On the other hand, some recent reports
have demonstrated the possible cell-cell communication function
of extracellular mRNA and miRNA [14–18]. Extracellular
miRNA may act like hormones [2].
Although the characterization, potential function and clinical
application of cell-free RNAs in human body fluids have been
demonstrated, relatively little is known about forms of their
existence, which should be essential for the understanding their
stability, origin, and mechanism for intercellular communication.
The diagnostic and prognostic potential of cell-free RNAs as
biomarkers relies mainly on their high stability, but RNA species
are inherently labile and easily degraded in extracellular
environments. To further spread the research and clinical
applications of extracellular RNAs, it is important to understand
the their very existence that could bring cellular RNAs into body
fluids and protect them from degradation. On the other hand, the
exploration of the physical nature of cell-free RNAs, which should
be related with mechanisms of their secretion from, and entrance
into cells, will shed light on their possible biological roles and
mechanisms.
On the basis of the characteristics of cell-free seminal mRNA
(cfs-mRNA), miRNA (cfs-miRNA) reported from our group [19]
and others [20], the cfs-mRNA and cfs-miRNA appear to be
potential noninvasive biomarkers for diseases of male reproductive
organs and forensic identification [12,13]. First, the concentration
(average 1.75 mg/L [19] or higher [20]) of cell-free RNA in
human seminal plasma is much higher than in other body fluids,
also with high stability. Second, human seminal plasma is a
mixture of fluids from the male reproductive organs, so it contains
many tissue specific mRNAs and miRNAs of these organs.
Moreover, because the cfs-mRNA and cfs-miRNA contain the
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it should be more representative than tissue biopsy, which is not
easily applied and accepted for male reproductive organs.
As for the possible function of cfs-mRNA and cfs-miRNA, it is
tempting to think that before ejaculation, extracellular RNAs
stored in luminal fluids of male reproductive organs could
commute between cells (maybe including sperm) and attribute to
the gene expression, given that temporal and spatial regulation of
gene expression in testis and epididymis is pivotal for normal
spermatogenesis and sperm maturation. In sperm, RNA can be
translated into proteins [21–23] and be delivered into oocyte
[24,25].
Some characteristics of human seminal plasma and male
reproductive organs may attribute to the large amounts of RNAs
in human seminal plasma, and to the forms of their existence.
Human seminal plasma contains significant amounts of seminal
microvesicles (SMVs) and proteins. SMVs are secreted from each
male reproductive organ [26–28]. The epididymis and prostate
release amounts of microvesicles into the glandular lumen via
apocrine secretion, named epididymosome and prostasome
[26,28]; In the process of sperm maturation, sperm residual
cytoplasm and cytoplasmic droplet are discarded from the nascent
spermatozoa, partially via microvesicle budding. Moreover, during
normal spermatogenesis, prominently germ cells undergo apopto-
sis, which may be important sources for both SMVs and
cytoplasmic complexes releasing into luminal tubules [29].
Therefore, we hypothesize male reproductive organ-derived cell-
free RNAs would be primarily sequestered within a variety of
SMVs or cytoplasmic complexes in order to escape from
degradation by extracellular RNases and be liberal present.
Although the presence of cfs-mRNA [19] and cfs-miRNA [20]
was reported, and their potential applications and functions were
proposed [12,13,19,20], their physical nature remained unclear.
In our previous study of the presence, integrity and stability of cfs-
mRNA [19], we observed significant reduction of cfs-mRNA
amounts after passing seminal plasma through filters (#0.45 mm)
or adding Triton X-100 into seminal plasma, whereas for cfs-
miRNA no reduction or slight reduction was observed in our
initial experiment (unpublished data) for the present study,
implying different physical nature of cfs-mRNA and cfs-miRNA.
Here we revealed the stability of cfs-miRNA, and explored the
physical nature of cfs-mRNA and cfs-miRNA, by quantifying male
reproductive organ-specific mRNAs, miRNAs, and piRNAs. To
our knowledge, this represents the first report of the existing forms
of cell-free RNAs in human seminal plasma. Very different forms
of the existence of cfs-mRNA and cfs-miRNA were found, which
should be responsible for their stability and help to spread their
clinical applications, and shed light on their origins and possible
roles in male reproduction.
Materials and Methods
Participant Recruitment and Seminal Plasma Isolation
The study was approved by the institutional review board at our
facility: Reproductive Medicine Review Board of Tongji Medical
College, and written informed consent was obtained from all
volunteers included in this study. Clinical investigation was
conducted according to the principles expressed in the Declaration
of Helsinki.
The healthy participants (normozoospermic individuals) were
selected from infertile couples who underwent assisted reproduc-
tion technology treatment for diagnosed female factor infertility, as
described previously [19]. Vasectomized individuals were recruit-
ed from Qichun County (Hubei province, China) by local Family
Planning Service Center. The mean age of the healthy participants
and vasectomized individuals was 32 years (range, 26–42 years).
The WHO’s standard criteria [30] for normozoospermia was
applied. All individuals had no family history of genetic diseases,
history of hyperpyrexia, malignancy, autoimmune disorders,
sexually transmitted diseases or inflammation of reproductive
organs. Individuals who worked in high temperature environments
or had occupational exposure to toxic chemicals or radiation were
also excluded.
Semen samples were obtained by masturbation after 3–5 days of
sexual abstinence and were allowed to liquefy within 30 min at
37uC. To harvest cell-free seminal plasma, we centrifuged seminal
samples twice at 4uC. After the first centrifugation at 1,600 g for
10 min at 4uC, the supernatant was then centrifuged at 16,000 g
for 10 min to remove cells and cell debris. The supernatant was
carefully collected for subsequent assays.
Stability Analysis of cfs-miRNA
In the following experiments of stability, semen plasma
filtration, and Triton X-100 treatment, we focused on cfs-miRNA,
because these have previously been performed on cfs-mRNA [19].
We left 5 seminal samples at room temperature for 0, 2, 4, 8,
and 24 h. At each time point, 0.2 ml seminal plasma was subjected
to RNA extraction for miRNA quantification. As a control for the
effect of seminal RNases, we spiked purified cfs-miRNA from
normozoospermic participants into seminal plasma of vasecto-
mized individuals (n=5). The amounts of testis-specific piRNAs,
which should exist in seminal plasma of normozoospermia but not
in the vasectomized individuals, were assessed.
Filtration and Triton X-100 Treatment of Seminal Plasma
Seminal plasma from 5 healthy individuals was respectively
divided into 5 aliquots: Two portions were individually passed
through filters (Millipore) with pore sizes of 0.45, and 0.22 mm.
One aliquot was added Triton X-100 to a final concentration of
1% (v/v) and incubated at room temperature for 20 min. The
remaining two control aliquots were not subjected to filtration, but
one of them was added Triton X-100 to a final concentration of
1% (v/v) after protection of RNA by the lysis reagent during RNA
extraction. These aliquots of seminal plasma were subjected to
RNA extraction for quantitative analysis of miRNAs. These
methods have previously been described [19,31].
Preparation and Treatment for SMVs
As microvesicles are commonly smaller than 1.0 mm, cell-free
seminal plasma was firstly passed through a 1.0 mm Protran Filter
(Whatman) to remove any remaining macromolecules and debris.
0.4 ml of this filtrate was adjusted with 8.6 ml of phosphate-
buffered saline (PBS) buffer (10 mM Na2HPO4, 1.8 mM
KH2PO4, 50 mM NaCl, 2.7 mM KCl, pH 7.4) to a 9 ml final
volume in a ultracentrifuge tube and spun at 100,000 g for 2 h in a
SW 70 Ti Rotor at 4uC to pellet the SMVs. The final pellet,
containing the SMVs, was then resuspended in sterile PBS and
prepared for follow-up studies. The presence and characterization
of SMVs was checked by transmission electron microscope.
Then, to disrupt any free RNA and RNA-binding proteins in
the suspensions of SMVs, RNase A (Fermentas) was added to these
suspensions at a final concentration of 100 mg/ml and incubated
for 15 min at 37uC. After that, these suspensions were immedi-
ately treated with 0.25% (w/v) trypsin (Sigma) for 10 min at 37uC.
Finally, the suspensions of SMVs were used for subsequent RNA
isolation for mRNA and miRNA quantification.
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As microvesicles was likely to be heterogeneous with a diameter
of 30 nm–1.0 mm, suspensions of SMVs obtained from another
group of 6 healthy participants were divided into 5 aliquots,
respectively. Four aliquots were individually passed through 4
filters of different pore sizes (0.80, 0.45, 0.20 and 0.10 mm). The
remaining aliquot was unfiltered. We then extracted the RNA
from 0.4 ml of the filtered and unfiltered aliquots of SMVs
suspensions for mRNA quantification.
Filtration and Protease K treatment for Supernatant
The supernatant after ultracentrifugation may contain tiny
microvesicles. Supernatants obtained from 4 healthy participants
were divided into 2 aliquots, respectively. One was passed through
a 0.10-mm filter. The remaining aliquot was unfiltered. Then RNA
was extracted from 0.2 ml of the filtered and unfiltered aliquots for
miRNA quantification.
As most of protein complexes should remain in the supernatant
after ultracentrifugation, we added protease K (Fermentas) to the
supernatant at a final concentration of 0.5% (w/v) and incubated
for 0, 15, 30 min and 1, 2 h. At each time point, 0.2 ml
supernatant was subjected to RNA extraction for miRNA
quantification.
RNA extraction
The seminal plasma, the suspension of SMVs, and the
supernatant after ultracentrifugation were subjected to RNA
extraction directly. Seminal plasma and SMVs were diluted to the
same volume as the supernatant, for the experiments of
comparisons between RNAs in seminal plasma, SMVs, and the
supernatant. Different protocol of RNA extraction was applied for
mRNA and miRNA assessment. The RNA extraction for mRNA
quantification was performed as described previously [19] with
minor modifications. Briefly, liquid for RNA isolation (0.4 ml) was
mixed with 0.8 ml TRIzol LS (Invitrogen). The mixture was
incubated at room temperature for 10 min. Then 0.22 ml of
chloroform was added and mixed by vigorous shaking. After
incubation at room temperature for 10 min, the mixture was
centrifuged at 12,000 g for 15 min at 4uC. The aqueous layer was
transferred to a new tube, mixed with isopropanol in a 1:1 ratio
and incubated at room temperature for 10 min. Then, the mixture
was centrifuged at 12,000 g for 10 min at 4uC. The RNA pellet
was dissolved in RNase-free water (0.1 ml) and then purified with
an RNeasy Kit (Qiagen) according to the manufacturer’s
instructions. Total RNA was finally eluted with 20 ml of RNase-
free water with RNase inhibitor (Fermentas).
As for the RNA extraction for miRNA quantification, 0.2 ml of
fluid was mixed with 0.25 ml TRI-reagent buffer (0.15 NaCl, 1%
SDS, 2.5 mM EDTA, 0.1 M Tris-HCl, pH 8.0). Then 9 mg PEG
20,000 (Sigma) was added to get a final concentration at 2% (w/v)
to remove polysaccharides, which is very rich in seminal plasma.
But for the suspension of SMVs, this step was skipped. The
mixture was incubated for 10 min at room temperature, followed
by centrifugation at 13,000 g for 10 min at 4uC. The aqueous
layer was transferred to a new tube for the Trizol LS procedure
according to the manufacturer’s instruction. Briefly, the aqueous
layer (0.4 ml) was mixed with 0.8 ml Trizol LS reagent and
incubated for 5 min at room temperature and then centrifuged at
12,000 g for 10 min at 4uC to remove insoluble material. The
cleared solution layer was transferred to a new tube and mixed
with 0.22 ml chloroform. The mixture was incubated for 10 min
at room temperature and centrifuged at 12,000 g for 15 min at
4uC and then the aqueous layer was transferred to a new tube.
Equal volume of isopropyl alcohol was added to the aqueous layer,
and the mixture was incubated for 10 min at room temperature
and centrifuged at 12,000 g for 10 min at 4uC. The RNA pellet
was washed with 75% ethanol. Finally, RNA was dissolved in
15 ml RNase-free water with RNase inhibitor.
To remove any contaminating DNA, DNase treatment
[Recombinant DNase I (RNase-free); Takara] was carried out
according to the manufacture’s instructions.
mRNAs and miRNAs Investigated
The genes that we selected were housekeeping gene (ACTB) and
male reproductive organ-specific transcripts (DDX4, PRM2,
DEFB129, SERPINA5, TGM4): (1) Housekeeping gene: b-actin
(ACTB, NM_001101); (2) Testis-specific genes: including whole
process spermatogenesis marker gene: DEAD (Asp-Glu-Ala-Asp)
box polypeptide 4 (DDX4, NM_001317), and post-meiotic
spermatogenic gene: Protamine 2 (PRM2, NM_002762); (3)
Epididymis-specific genes: b-defensin 129 (DEFB129,
NM_080831); (4) Seminal vesicle- specific genes: serpin peptidase
inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member
5(SERPINA5, NM_000624); (5) Prostate-specific genes: transglu-
taminase 4 (TGM4, NM_003241). All primers were designed to
span the intron. Information of these genes and primer sequence is
given in supplemental data Table S1.
Two miRNAs (miR-34a, miR-141) existing widely in epithelial
cells of male reproductive organs, two testis-specific miRNA (miR-
202, miR-449a), and two piRNAs (piR-013423, piR-023386) were
involved in this study. See supplemental data Table S2 for the
information of probes and primers.
cDNA Synthesis and qPCR for mRNAs
Reverse-transcription was performed for synthesizing cDNA
with the RevertAidTM First Strand cDNA Synthesis Kit
(Fermentas) according to the manufacturer’s instruction.
Quantitative real-time PCR (qPCR) for mRNAs was performed
as described previously [19] with an Mx3000P thermocycler
(Stratagene) and with SYBR Green I used for detecting the
fluorescence of amplified products. PCR conditions were: 95uC for
10 min (initial denaturation) and 40 cycles of 25 sec at 95uC
(denaturation), 30 sec at the annealing temperature (Table S1),
30 sec at 72uC (elongation), and 8 sec at 81uC (fluorescence
measurement). A melting curve was generated at the end of every
run to ensure product uniformity. The gel-extracted PCR products
were inserted in the pCR2.1-TOPO vectors (Invitrogen) and were
subjected to DNA sequencing to confirm the correct amplification.
To quantify these 6 different mRNAs, calibration curves were
generated by use of serial dilutions of the plasmid DNA.
cDNA Synthesis and qPCR for miRNAs
The quantity of miRNAs was determined using qPCR based on
enzymatic stem-loop probes ligation as described previously [32],
which has been shown to be highly specific for the mature
miRNA. Briefly, for cDNA synthesis, total RNA was mixed with
probes (20 fmol) and incubated at 65uC for 3 min on a Gradient
thermal cycler (Eppendorf), then slowly cooled to room temper-
ature (about 30 min), and finally placed on ice for the formation of
nicked heteroduplex structures. Enzymatic ligation was performed
on the thermal cycler by incubation at 22uC for 1 h and 65uC for
10 min with the presence of T4 DNA ligase (Fermentas), DNA
ligation buffer, PEG 4000, and RNase inhibitor in a final volume
of 20 ml.
Real-time PCR was performed with the Mx3000P thermo-
cycler. The ligation product (2 ml) was pipetted as PCR templates
into DimerEraser SYBR Green Mastermix (Takara) to obtain a
20 ml PCR reaction. The reactions were incubated in a 96-well
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60uC for 20 sec, and 72uC for 20 sec. To ensure product
uniformity, a melting curve was generated at the end of every
run, and the PCR product was analyzed on an 8% polyacrylamide
gel (length: 26 cm). Calibration curves were constructed by use of
serial dilutions of synthetic miRNA with known concentration.
Statistic Analysis
Statistical analyses were performed using SigmaStat 2.03
software (SPSS Inc.). The Friedman test was used for analyzing
the stability of cfs-miRNA, proportions of RNAs that included
within SMVs, and for experiments of Triton X-100 treatment and
all filtrations. When this test gave significant results, it was followed
by Student–Newman–Keuls (SNK) test. P,0.05 was considered as
significant.
Results
Stability of cfs-miRNA
The stability of cfs-miRNA was evaluated by a time-course (0, 2,
4, 8, and 24 h, at room temperature) analysis of 4 miRNAs and 2
piRNAs involved in this study. All these cfs-miRNAs were stable at
least within 24 h. We observed no significant degradation of any
miRNA at any of these serial time points (supplemental data
Figure S1; P.0.05, SNK test). While in the spiked control,
exogenous RNA (contain piRNA from testis) obtained from
seminal plasma of healthy individuals was added into the seminal
plasma of vasectomized participants (do not contain piRNA); Only
very small amount (11.7% for piRNA-013423, 12.3% for piRNA-
023386) of piRNA remained after 2 min incubation at room
temperature, confirming the RNase activity in semen.
Most cfs-miRNA Remained after Filtration or Triton X-100
Treatment
Filtration and Triton X-100 treatment were taken as the simple
and preliminary methods to provide information of the complexes
the cfs-miRNA were bound with. The clearly reductive effects of
these treatments on cfs-mRNA have been observed in our previous
study [19]. But for cfs-miRNA, after filtrating seminal plasma
through 0.45-, or 0.22-mm pores, no significant change of the
amount of any miRNA was observed (Figure 1; P.0.05, SNK
test). After incubation with 1% (v/v) Triton X-100 at room
temperature for 20 min, although significant degradation of
miRNA in seminal plasma was observed (Figure 1; P,0.05,
SNK test), the main part of them remained detectable. The mean
percentages of remained miRNA varied from 63.4% (piR-023386)
to 75.8% (piR-013423). In contrast, only 2.3% of ACTB and no
DDX4 mRNAs were detected under the same incubation [19].
Isolation and Characterization of SMVs
The existence of significant amounts of SMVs in human
seminal plasma, and the very different reductive effect of filtration
and Triton X-100 on cfs-mRNA [19] and cfs-miRNA (Figure 1)
prompted us to isolate the SMVs. The SMVs were isolated
successfully in all samples. Under transmission electron micro-
scope, these SMVs are primarily 30 nm-0.5 mm in diameter
(Figure 2A).
cfs-mRNA in SMVs with Different Size
We then further evaluated the proportions of cfs-mRNA and
cfs-miRNA that presents in the form of SMVs. The RNA in the
seminal plasma and its SMVs suspension was extracted for
comparing the amounts of 6 mRNAs, 4 miRNAs, and 2 piRNAs
by qPCR.
In initial experiments (unpublished data), we observed that the
amounts of cfs-mRNA in seminal plasma were almost the same as
in the SMVs. To confirm this interesting result, seminal samples
from 16 healthy participants were analyzed. Overall, no obvious
change in ACTB, DDX4, PRM2, DEFB129, SERPINA5 and TGM4
mRNA levels between concentrations of total cfs-mRNA in
seminal plasma and the part of SMVs-sequestered mRNA was
observed (Figure 2B, Table S3; n=16, P .0.05, SNK test). As for
the mRNA in the supernatant, qPCR failed or gave a high
threshold cycle value in most cases. Thus, SMVs- sequestered
mRNA constituted the majority of cfs-mRNA.
As microvesicles was likely to be heterogeneous in size [33–35],
the SMVs- sequestered nature of cfs-mRNA was further
investigated by filtrating SMVs through filters with different pore
sizes (0.80, 0.45, 0.20, and 0.10 mm). To exclude the possibility
that these filters bind RNA nonspecifically, we also filtered purified
RNA through filters with different size pores and recovered more
than 85% of these 6 mRNAs. Clearly observable concentration
reductions in each transcript after 0.80, 0.45, 0.20 and 0.10-mm
filtration step were observed (Figure 3, Table S4; P,0.01, SNK
test).
In contrast, only small part of cfs-miRNA was detected in the
SMVs (Figure 2C), with median percentage (relative to seminal
plasma; n=6) varying from 18.4% (miR-141) to 28.5% (piR-
023386). The proportions of SMVs- sequestered miRNAs were
not related with different organs.
Many cfs-miRNAs were Associated with Protein
Because only a small part of cfs-miRNA was found in the
SMVs, so we determined the proportion of miRNA in the
supernatant after ultracentrifugation for SMVs recovery. The
major part of cfs-miRNA existed in the supernatant, with median
percentage (relative to seminal plasma; n=6) varying from 67.2%
(piR-013423) to 86.5% (miR-141) (Figure 4A).
We continued to explore the existing form of the majority of cfs-
miRNA in the supernatant. The supernatant was filtered through
the filter with the 0.10- mm pore, through which it is hard to filter
the seminal plasma directly because of the viscosity. Almost all of
cfs-miRNA passed the filter (Supplementary data Figure S2). Even
in some cases, a light increase was observed in the filtrate.
Considering that abundant proteins exist in the seminal plasma,
and most of them should remain in the supernatant, we then
digested the supernatant with protease K at a high concentration
(0.5%, w/v). Generally, within 15 min, all cfs-miRNA we assessed
were significantly degraded in the presence of protease K, while
remained stable in the untreated control. The representative
results of some cfs-miRNAs from one sample were shown in
Figure 4B.
Discussion
To reveal the physical nature of cell-free RNAs can provide
insight into mechanisms accounting for their stability and
intercellular communication. Here we found very different forms
between the existence of cfs-mRNA and cfs-miRNA, and
discussed the implications for their origin, function and developing
them as non-invasive biomarkers.
Our results on cfs-mRNAs revealed that almost all of them
existed in SMVs. This result was confirmed in 16 healthy
individuals, without any significant differences between the
amount of cfs-mRNAs we quantified in the seminal plasma and
in the SMVs. All these 6 different genes that specifically expressed
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results [19] also showed the significant degradation of cfs-mRNA
by incubating seminal plasma with Triton X-100, which could
enhance the permeability of the SMVs membrane and expose
RNA to RNase in seminal plasma. Therefore, these data
demonstrated cfs-mRNA was mainly contained inside SMVs
and was thereby protected from external RNases by the
surrounding membrane. As for cell-free mRNAs in other body
fluids, previous report [36,37] on circulating mRNAs suggested
that some of them were contained inside microvesicles.
As for the cfs-miRNA, we first demonstrated its stability at least
within 24 h at room temperature, which apparently cannot be
explained by the intrinsic stability of miRNA [38]. Our results
indicated that small vesicles contribute minimally to the
concentration of cfs-miRNAs. First, only around 20% of cfs-
miRNA was contained inside SMVs, as demonstrated by the
results of Triton X-100 treatment and the cfs-miRNA proportion
in SMVs. Second, no significant change of the amount of any
miRNA was observed after filtration seminal plasma through 0.45-
, or 0.22-mm pores, suggesting the sizes of these SMVs-sequestered
cfs-miRNAs were below 0.22 mm. But the possibility cannot be
excluded that few of them existed in SMVs above 0.22-mm, while
filtration may enhance the efficacy of RNA extraction.
Further experiments on the cfs-miRNAs in the supernatant
reveal that most of cfs-miRNA was bound with proteins. Almost all
cfs-miRNA in the supernatant passed through the 0.10-mm filter.
Dramatical degradation of cfs-miRNA in the supernatant was
observed after the 15-min incubation with 0.5% (w/v) protease K,
and only trace amounts of them remained after the 30-min
incubation. Some previous studies revealed the existence of
miRNAs in membrane-bound microvesicles acquired from the
cell-culture medium [16,39] or body fluids [40,41], and lead to the
dominant hypothesis that vesicles, as carriers of cell-free miRNAs,
protect them against degradation. However, recent reports [42,43]
Figure 1. The effect of filtration and Triton X-100 on the amount of cfs-miRNAs. Seminal plasma was filtered through 0.45-, and 0.22-mm
pores, or incubated with 1% (v/v) Triton X-100 at room temperature for 20 min. The amount of miRNAs was normalized to the unfiltered aliquot. Each
column represents the mean of 5 independent samples. Error bars indicate the SD.
doi:10.1371/journal.pone.0034566.g001
Figure 2. Characterization of SMVs and the proportions of cfs-mRNAs and cfs-miRNAs in SMVs. SMVs (A) were approximately 30 nm-
0.5 mm in diameter using a transmission electron microscope. The amount of mRNAs (B, n=16) and miRNAs (C, n=6) in the SMVs was normalized to
the amount in the seminal plasma. Horizontal lines within the boxes denote the median. The boxes and whiskers represent intervals between the
25th to 75th percentiles, and the 2.5th to 97.5th percentiles, respectively.
doi:10.1371/journal.pone.0034566.g002
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protein, a functional protein of miRNA-induced silencing
complex. Also, recent results [44] indicate many circulating
miRNA in plasma existed in platelets, which may overwhelm the
disease-, or tissue-specific signature if were not removed. Our
results lead us to believe that most cfs-miRNA was released and
protected from degradation in the form of miRNA-induced
silencing complex, while only small proportion in the form of
SMVs.
SMVs are regarded as very stable ultrastructural organizations
and vehicles for intercellular communication, which should
contribute to the stability, origin, and possible function of
extracellular RNAs in semen.
Although coherent similar results were observed for these
different tissue-specific cfs-mRNAs and cfs-miRNAs, the possible
origin of SMVs from these organs should be different. Exosomes
and shedding vesicles from epithelium of epididymis, prostate, and
seminal vesicle [26–28,35,45,46] may be responsible for the
SMVs-sequestered cfs-mRNA and cfs-miRNA through apocrine
secretion or other mechanism. As for the testis-specific mRNAs
and miRNAs, although most of large and medium-sized sperm
residual body of apoptotic germ cells were phagocytized [47],
some smaller shedding vesicles might be redundant cargoes
Figure 3. The representative result of heterogeneous in quantity of cfsRNA according to size of SMVs. SMVs suspensions from 6 healthy
participants were filtered through 0.80, 0.45, 0.22 and 0.10 mm pores. The amount of mRNAs at each pore size was normalized to the unfiltered
aliquot, respectively. Horizontal lines within the boxes denote the median. The boxes represent the interval between the 25th and 75th percentiles,
and the whiskers represent the interval between the 2.5th and 97.5th percentiles.
doi:10.1371/journal.pone.0034566.g003
Figure 4. Most cfs-miRNAs remained in the supernatant and were dramatically degraded by intense protease K digestion. The
amount of miRNAs in the supernatant (A) was normalized to the seminal plasma. Horizontal lines within the boxes denote the median (n=6). The
boxes and whiskers represent intervals between the 25th to 75th percentiles, and the 2.5th to 97.5th percentiles, respectively. For protease K
digestion (B), at each time point, the supernatant incubated with 0.5% (w/v) protease K (circle dots) or not (square dots) was subjected to miRNA
quantification. The amounts at time 0 were taken as 1.0.
doi:10.1371/journal.pone.0034566.g004
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testis, RNA binding proteins can stabilize cellular mRNAs
transcribed before mid-spermatogenesis and store them for
translation during spermiogenesis period, during which de novo
transcription is halted permanently [48,49]. But out results suggest
that this kind of protection do not contribute to the large amounts
of cfs-mRNAs. We also observed that the amounts of SMVs-
sequestered cfs-mRNA were highly variable depending on the
different sizes of SMVs (Figure 3). As microvesicles ,0.10 mm
were identified as exosomes [33,34], our results showed the
amounts of cfs-mRNA were richer inside shedding vesicles (usually
their sizes are 0.10–1 mm [34]), which could be the microparticles
and/or the apoptotic blebs [34].
On the other hand, many investigations [14–18] have proposed
extracellular mRNA and miRNA as means of intercellular
communications by vesicle-mediated transfer between cells. It is
tempting to think that extracellular RNAs in luminal fluids of male
reproductive organs could commute between cells and attribute to
the gene expressions. Indeed, delivering molecules by microves-
icles have been demonstrated in male reproductive system. For
instance, one molecular mechanism for sperm maturation is
delivering proteins into sperm by epididymosome [50–52]; SMVs
or prostasome was also found to attribute to sperm function by
delivering molecules into sperm [53–55]. Our previous results [19]
demonstrated that cfs-mRNA contained intact transcripts, which
could be template for protein translation.
This finding may contribute to the strategy of developing cfs-
mRNA and cfs-miRNA as biomarkers of male reproductive
system. Seminal plasma may be the most complicated type and
particularly challenging for RNA extraction among all human
body fluids, due to high level of proteins, polysaccharides, and
other secondary metabolites. But harvesting SMVs for cfs-mRNA
recovery by routine methods could be a simple and better
alternative because it avoids the influence of proteins, polysaccha-
rides, and other compounds. Also, there are many kinds of
methods for protein fractionation, enrichment, concentrating, and
recovery, through which the protein complexes could be collected
for recovering most amounts of cfs-miRNA. Another issue is the
existence of physical barrier between blood and male reproductive
system, such as the blood–testis barrier and blood–epididymis
barrier. Cell-free mRNAs and miRNAs from testis or epididymis
may be hard to be detected in blood, given that they were enclosed
in the microvesicles or bound with protein complexes, which
should not pass these barriers.
In conclusion, this work demonstrated that most cfs-mRNA was
contained inside SMVs, while the majority of cfs-miRNA was
bound with protein complexes. Our data shed light on the strategy
of developing cfs-mRNA and cfs-miRNA as biomarkers of male
reproductive system. Microvesicles have been shown to transfer
proteins and RNA from cell to cell and play a role in intercellular
communication. Whether the SMVs or the protein-sequestered
cfs-mRNA or cfs-miRNA, which is stored in male reproductive
organs before ejaculation, has function in male reproduction need
further investigation.
Supporting Information
Figure S1 Stability of cfs-miRNAs and piRNAs. Seminal plasma
samples of normozoospermic individuals were incubated at room
temperature up to 24 h. Amounts of miRNAs and piRNAs were
measured by real time PCR at each time point and normalized to
the amount at time 0. The last two spiked piRNAs were measured
after adding the recovered cfs-miRNA into seminal plasma of
vasectomized participants, which should not contain piRNAs.
Each column represents the mean of 5 independent samples. Error
bars indicate the SD.
(TIF)
Figure S2 The amount of miRNAs in the supernatant was not
affected by filtration through the 0.10-mm filter. Each dot
represents the amount of miRNA after filtration (relative to the
unfiltered aliquot).
(TIF)
Table S1 Specific primers used for RT-PCR of mRNAs.
(DOC)
Table S2 Ligation probes and PCR primers for miRNAs.
(DOC)
Table S3 Median levels of gene mRNAs in cell-free seminal
RNA and SMVs.
(DOC)
Table S4 Relative mRNA concentrations in SMVs filtered
through different sizes pores.
(DOC)
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